LE Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
Public ClinicalTrials.gov record NCT02786901. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multi-Center, Double-Masked, Vehicle-Controlled, Randomized, Parallel-Group Study to Assess Loteprednol Etabonate Ophthalmic Gel, (BID and TID) Versus Vehicle Gel
Study identification
- NCT ID
- NCT02786901
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bausch & Lomb Incorporated
- Industry
- Enrollment
- 600 participants
Conditions and interventions
Conditions
Interventions
- Loteprednol Etabonate Ophthalmic Gel dosed BID Drug
- Loteprednol Etabonate Ophthalmic Gel dosed TID Drug
- Vehicle Gel Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2016
- Primary completion
- Jun 12, 2017
- Completion
- Jun 30, 2017
- Last update posted
- Jan 7, 2021
2016 – 2017
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Valeant Site 01 | Phoenix | Arizona | 85032 | — |
| Valeant Site 03 | Oceanside | California | 92056 | — |
| Valeant Site 05 | Miami | Florida | 33143 | — |
| Valeant Site 04 | Quincy | Massachusetts | 02169 | — |
| Valeant Site 06 | Kansas City | Missouri | 64111 | — |
| Valeant Site 02 | St Louis | Missouri | 63131 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02786901, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 7, 2021 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02786901 live on ClinicalTrials.gov.